Syquant Capital SAS’s Qiagen QGEN Stock Holding History

Syquant Capital SAS’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-165,654	Closed	-$7.52M	–	64
2020 Q2	$7.52M	Buy	+165,654	New	+$7.41M	3.5%	6

Other funds holding QGEN

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Syquant Capital SAS's QGEN Position: Q3 2020 in Review

Syquant Capital SAS sold out of Qiagen (QGEN) in Q3 2020, closing a stake of 165,654 shares — an estimated $7.52M sold.

Syquant Capital SAS first reported a position in QGEN in Q2 2020 and held it in 1 quarter. The position peaked at $7.52M in Q2 2020. 252 funds tracked by Wall St. Rank hold QGEN as of Q3 2020.

Syquant Capital SAS reported no remaining Qiagen position as of Q3 2020 after selling out during the quarter.
Syquant Capital SAS sold 165,654 Qiagen shares in Q3 2020, an estimated $7.52M.
Syquant Capital SAS first reported a position in Qiagen in Q2 2020 and held it in 1 quarter.
Syquant Capital SAS's Qiagen position peaked at $7.52M in Q2 2020.
252 funds tracked by Wall St. Rank held Qiagen as of Q3 2020.

Based on Syquant Capital SAS's 13F filing for Q3 2020, filed 21 Oct 2020.